Erik Harris has served on our board of directors since October 2024.
Mr. Harris currently serves as Chief Commercial Officer and Executive Vice President at Ultragenyx. Prior to his appointment as Chief Commercial Officer, Mr. Harris served as the Senior Vice President and Head of North American Commercial Operations at Ultragenyx. Before joining Ultragenyx, he spent six years at Crescendo Bioscience, most recently as Vice President of Commercial. Earlier in his career, Mr. Harris served as Vice President of Marketing at Intermune, Inc., and held positions in the commercial organizations at Elan Pharmaceuticals, Inc., Genentech, Inc., and Bristol-Myers Squibb Company. He currently serves on the Board of Directors at Denali Therapeutics.
At the start of his professional career, Mr. Harris served as a Lieutenant Commander in Naval Aviation and Congressional Fellow for the United States Navy. Mr. Harris received his M.B.A. from the Wharton School of Business, and a B.S. from the United States Naval Academy.
